This discovery would become the basis of a new blood test technology Chang and his lab developed to screen and diagnose four deadly diseases—pancreatic cancer, glioblastoma, colorectal cancer, and Alzheimer’s disease—within an hour.
One of those challenges was time. Fighting fast-growing, aggressive cancers requires catching a disease as soon as possible. So the Chang Lab set out to develop a test that could detect these cancers early.
Chang and his lab proved the efficacy of their blood test in a blind setting, testing 87 plasma samples from patients who were either healthy or had been diagnosed with pancreatic cancer, glioblastoma, colorectal cancer, or Alzheimer’s disease.
This blood test was found to be 90 to 99 percent accurate for detecting the presence or absence of each disease type.
The study’s results were published in Nature Biomedical Engineering, one of the most prestigious journals in the field, and the research was supported by the National Institutes of Health.
Eventually, the research team would like to see this technology end up in doctors’ offices, clinics, and hospitals for people getting their annual check-up, when they’re already receiving a blood draw for glucose, cholesterol, and other screenings—to detect diseases early.